Dumb health care devices are no longer OK. With medical errors and redundancies costing us $750 billion a year, the push is on to digitize all forms of health information.

That’s probably one of the reason investors are betting another $2 million on Berkeley, California-based smart stethoscope company Eko.

Eko makes a small adapter device, called Eko Core, that fits between the earpiece and chest piece of a stethoscope. It routes the heart sounds it hears to a phone via Bluetooth LE. The phone app then sends the audio data up to the cloud, where a specialist can pull it down and listen to it.

Using the Core electronic stethoscope attachment and connected software, clinicians can amplify, record, save, share, and analyze patient heart sounds from the stethoscope they already own, Eko said in a statement. The ability to evaluate cardiac health with unprecedented clarity and use recorded heart sounds for short-term and long-term patient monitoring will reduce unnecessary cardiac screenings and improve continuity of care, the company added.

Eko says its Core stethoscope is the first stethoscope to be wirelessly connected, enabling all manner of heart sound analytics and monitoring.

The new investment round is led by Founder.org Capital and Splunk founder Michael Baum. Stanford University’s StartX Fund and John Noonan, former senior advisor to the U.S. Secretary of Health and Human Services, also contributed. The round brings Eko’s funding total to about $2.8 million.

“Though the stethoscope is an icon of medicine and one of clinicians’ most trusted tools, it is a 200-year old technology greatly in need of an update,” said Eko CEO and cofounder Connor Landgraf. “This investment round and upcoming UCSF study is a momentous step towards a new age in stethoscope intelligence and cardiac monitoring.”

The UCSF clinical study will be used to validate the $199 Core’s clinical efficacy in advance of the summer 2015 launch of the product. Food and Drug Administration approval is pending.

The mobile and web-based software that go with the smart stethoscope will be free for individual clinicians. Eko will sell an enterprise version of the software platform to clinics, hospitals, and health systems.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.